A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer

The results of the present study have shown that bicalutamide/raloxifene treatment is well tolerated. However, limited clinical activity occurred in men with CRPC who had previously undergone secondary hormonal therapy or chemotherapy.